Cidara Therapeutics Announces Pricing of Initial Public Offering, 4.8M At $16.00/Share
April 15, 2015 at 07:31 AM EDT
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal ...